4
Changes in Ownership
Elicio Therapeutics, Inc. Filed Acc 0001796436-26-000002
Options or other derivatives
- CEO, President and Director acquired 186,944 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Connelly Robert · CEO, President and Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-16 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +186,944 | 186,944 | D |
Loading xslF345X06/wk-form4_1784319208.xml…